Mersana Therapeutics to Host Conference Call Announcing First Quarter 2021 Financial Results and Business Updates
CAMBRIDGE, Mass., May 03, 2021 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it will host a conference call and webcast on Monday, May 10, 2021 at 4:30 p.m. ET to report financial results for the first quarter ended March 31, 2021 and provide business updates.
To access the call, please dial 877-303-9226 (domestic) or 409-981-0870 (international) and provide the Conference ID 5046849. A live webcast of the presentation will be available on the Investors & Media section of the Mersana website at www.mersana.com.
Investor & Media Contact
Keynote Presentation - Eric Burger, Former FCC CTO
Networking LIVE! Reception - On the Amazing Spacious Seaside Patio of the Loews Miami Beach Resort
Is Your AI Project Set Up To Succeed?